Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Record History shows updates to Study Status and Recruitment Status across versions, indicating changes in the trial's activity and enrollment status.
    Difference
    0.1%
    Check dated 2025-11-03T01:12:08.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Release 3.2.0 includes a prominent government funding/operating status notice and updates the version from 3.1.0 to 3.2.0.
    Difference
    13%
    Check dated 2025-10-05T09:56:57.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T03:12:46.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Added: Revision: v3.0.2. Deleted: Revision: v3.0.1 and Back to Top. The page now reflects the new revision and has removed a back-to-top UI element.
    Difference
    0.8%
    Check dated 2025-09-13T17:17:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.8%
    Check dated 2025-09-06T14:59:20.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.
    Difference
    7%
    Check dated 2025-08-30T11:46:02.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.